Literature DB >> 10381292

Prevalence of risk factors of coronary heart disease in Turks living in Germany: The Giessen Study.

M Porsch-Oezçueruemez1, Y Bilgin, M Wollny, A Gediz, A Arat, E Karatay, A Akinci, K Sinterhauf, H Koch, I Siegfried, R von Georgi, G Brenner, H U Kloer.   

Abstract

Turkish people represent the majority of immigrants in Germany. Even though a high proportion of Turks has been living in Germany since about 20 years, little is known about risk factors of coronary heart disease (CHD) in this population. In this study a sample of 325 male and 155 female Turks are investigated, who voluntarily underwent a health check-up in Germany. Data about the presence of CHD, risk factors and blood parameters were collected. Mean residence time was 21 and 17 years (males/females). A low percentage of female participants was observed compared to the general Turkish population in Germany. Age adjusted prevalence of CHD reached 9.5% in males and 6.7% in females, respectively. Dyslipoproteinemia (DLP) showed the highest prevalence of all risk factors investigated in both genders. Total cholesterol (TC) levels were comparable to those of other western countries and remarkably higher than reported for the population in Turkey. Besides this, low high density lipoprotein-cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) levels could be found in the majority of the sample. The highest odds ratios for CHD were estimated for stress and hypertension in males and obesity in females. It is concluded that Turkish immigrants in Germany showed an assimilation of lipid pattern to western populations. However, reasons for low HDL-C levels remain unclear. Changes in the lipid metabolism chiefly seem to contribute to the risk factor pattern of Turkish immigrants in Germany.

Entities:  

Mesh:

Year:  1999        PMID: 10381292     DOI: 10.1016/s0021-9150(99)00054-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  The Mosque Campaign: a cardiovascular prevention program for female Turkish immigrants.

Authors:  Angelika Bader; Doris Musshauser; Filiz Sahin; Hayriye Bezirkan; Margarethe Hochleitner
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

2.  Glucuronic acid epimerase is associated with plasma triglyceride and high-density lipoprotein cholesterol levels in Turks.

Authors:  Uğur Hodoğlugil; David W Williamson; Yi Yu; Lindsay A Farrer; Robert W Mahley
Journal:  Ann Hum Genet       Date:  2011-05       Impact factor: 1.670

3.  Obstructive sleep apnea, posttraumatic stress disorder, and health in immigrants.

Authors:  Bengt B Arnetz; Thomas Templin; Waleed Saudi; Hikmet Jamil
Journal:  Psychosom Med       Date:  2012-09-28       Impact factor: 4.312

4.  Difficulties in health care for female Turkish immigrants with type 2 diabetes: a qualitative study in Vienna.

Authors:  Elif Biyikli Gültekin
Journal:  Wien Klin Wochenschr       Date:  2017-04-05       Impact factor: 1.704

5.  Cardiovascular risk factors in Turkish immigrants with type 2 diabetes mellitus: comparison with Dutch patients.

Authors:  Paul J M Uitewaal; Alex N Goudswaard; Lielith J Ubink-Veltmaat; Lielith J Ubnik-Veltmaat; Marc A Bruijnzeels; Arno W Hoes; Siep Thomas
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

6.  Dietary fat quality and coronary heart disease prevention: a unified theory based on evolutionary, historical, global, and modern perspectives.

Authors:  Christopher E Ramsden; Keturah R Faurot; Pedro Carrera-Bastos; Loren Cordain; Michel De Lorgeril; Laurence S Sperling
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-08

7.  Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population.

Authors:  Ugur Hodoglugil; David W Williamson; Robert W Mahley
Journal:  J Lipid Res       Date:  2009-09-04       Impact factor: 5.922

8.  Prevalence of Cardiovascular Disease Risk Factors in Migrants Participating in the PEP Family Heart Study, Nuremberg.

Authors:  Gerda-Maria Haas; Klaus-Georg Parhofer; Peter Schwandt
Journal:  Int J Prev Med       Date:  2010
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.